From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
Line 1: |
Line 1: |
- | [[Image:1byg.gif|left|200px]] | + | {{Seed}} |
| + | [[Image:1byg.png|left|200px]] |
| | | |
| <!-- | | <!-- |
Line 9: |
Line 10: |
| {{STRUCTURE_1byg| PDB=1byg | SCENE= }} | | {{STRUCTURE_1byg| PDB=1byg | SCENE= }} |
| | | |
- | '''KINASE DOMAIN OF HUMAN C-TERMINAL SRC KINASE (CSK) IN COMPLEX WITH INHIBITOR STAUROSPORINE'''
| + | ===KINASE DOMAIN OF HUMAN C-TERMINAL SRC KINASE (CSK) IN COMPLEX WITH INHIBITOR STAUROSPORINE=== |
| | | |
| | | |
- | ==Overview==
| + | <!-- |
- | The crystal structure of the kinase domain of C-terminal Src kinase (CSK) has been determined by molecular replacement, co-complexed with the protein kinase inhibitor staurosporine (crystals belong to the space group P21212 with a=44.5 A, b=120.6 A, c=48.3 A). The final model of CSK has been refined to an R-factor of 19.9 % (Rfree=28.7 %) at 2.4 A resolution. The structure consists of a small, N-terminal lobe made up mostly of a beta-sheet, and a larger C-terminal lobe made up mostly of alpha-helices. The structure reveals atomic details of interactions with staurosporine, which binds in a deep cleft between the lobes. The polypeptide chain fold of CSK is most similar to c-Src, Hck and fibroblast growth factor receptor 1 kinase (FGFR1K) and most dissimilar to insulin receptor kinase (IRK).Interactions between the N and C-terminal lobe are mediated by the bound staurosporine molecule and by hydrogen bonds. In addition, there are several water molecules forming lobe-bridging hydrogen bonds, which may be important for maintaining the catalytic integrity of the kinase. Furthermore, the conserved Lys328 and Glu267 residues utilise water in the formation of a molecular pivot which is essential in allowing relative movement of the N and C-terminal lobes. An analysis of the residues around the ATP-binding site reveals structural differences with other protein tyrosine kinases. Most notable of these are different orientations of the conserved residues Asp332 and Phe333, suggesting that inhibitor binding proceeds via an induced fit.These structural observations have implications for understanding protein tyrosine kinase catalytic mechanisms and for the design of ATP-mimicking inhibitors of protein kinases. | + | The line below this paragraph, {{ABSTRACT_PUBMED_9878439}}, adds the Publication Abstract to the page |
| + | (as it appears on PubMed at http://www.pubmed.gov), where 9878439 is the PubMed ID number. |
| + | --> |
| + | {{ABSTRACT_PUBMED_9878439}} |
| | | |
| ==About this Structure== | | ==About this Structure== |
Line 32: |
Line 36: |
| [[Category: Protein kinase]] | | [[Category: Protein kinase]] |
| [[Category: Staurosporine]] | | [[Category: Staurosporine]] |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 12:06:59 2008'' | + | |
| + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 19:55:04 2008'' |
Revision as of 16:55, 30 June 2008
Template:STRUCTURE 1byg
KINASE DOMAIN OF HUMAN C-TERMINAL SRC KINASE (CSK) IN COMPLEX WITH INHIBITOR STAUROSPORINE
Template:ABSTRACT PUBMED 9878439
About this Structure
1BYG is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine., Lamers MB, Antson AA, Hubbard RE, Scott RK, Williams DH, J Mol Biol. 1999 Jan 15;285(2):713-25. PMID:9878439
Page seeded by OCA on Mon Jun 30 19:55:04 2008